MOTOR FUNCTION IN THE 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-TREATED MOUSE

被引：55
|
作者：
DONNAN, GA [1 ]
WILLIS, GL [1 ]
KACZMARCZYK, SJ [1 ]
ROWE, P [1 ]
机构：
[1] PRINCE HENRYS HOSP,DEPT PSYCHOL MED,MELBOURNE,VIC 3004,AUSTRALIA
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 1987年 / 77卷 / 2-3期
关键词：
D O I：
10.1016/0022-510X(87)90121-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：185 / 191
页数：7
相关论文
共 50 条
  • [1] Apoptosis in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice
    Fukudo, T
    Takahashi, J
    Xiang, F
    Tanaka, J
    [J]. BRAIN PATHOLOGY, 2000, 10 (04) : 787 - 787
  • [2] Neuronal cell death in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
    Fukuda, T
    Takahashi, J
    Tanaka, J
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (05): : 462 - 462
  • [3] SPINAL-CORD METABOLISM OF THE 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-TREATED MONKEY
    SCHWARTZMAN, RJ
    ALEXANDER, GM
    [J]. BRAIN RESEARCH, 1985, 337 (02) : 263 - 268
  • [4] A major metabolite of bupropion reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets
    Hansard, Matthew J.
    Jackson, Michael J.
    Smith, Lance A.
    Rose, Sarah
    Jenner, Peter
    [J]. BEHAVIOURAL PHARMACOLOGY, 2011, 22 (03): : 269 - 274
  • [5] An appraisal of the antiparkinsonian activity of piribedil in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets
    Smith, L
    DeSalvia, M
    Jenner, P
    Marsden, CD
    [J]. MOVEMENT DISORDERS, 1996, 11 (02) : 125 - 135
  • [6] TREATMENT WITH GM1 GANGLIOSIDE RESTORES STRIATAL DOPAMINE IN THE 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-TREATED MOUSE
    HADJICONSTANTINOU, M
    NEFF, NH
    [J]. JOURNAL OF NEUROCHEMISTRY, 1988, 51 (04) : 1190 - 1196
  • [7] EPIDERMAL GROWTH-FACTOR ENHANCES STRIATAL DOPAMINERGIC PARAMETERS IN THE 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-TREATED MOUSE
    HADJICONSTANTINOU, M
    FITKIN, JG
    DALIA, A
    NEFF, NH
    [J]. JOURNAL OF NEUROCHEMISTRY, 1991, 57 (02) : 479 - 482
  • [8] Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates
    Hansard, MJ
    Smith, LA
    Jackson, MJ
    Cheetham, SC
    Jenner, P
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (03): : 952 - 958
  • [9] Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey
    Boraud, T
    Bezard, E
    Stutzmann, JM
    Bioulac, B
    Gross, CE
    [J]. NEUROSCIENCE LETTERS, 2000, 281 (2-3) : 75 - 78
  • [10] Pallidal border cells: An anatomical and electrophysiological study in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey
    Bezard, E
    Boraud, T
    Chalon, S
    Brotchie, JM
    Guilloteau, D
    Gross, CE
    [J]. NEUROSCIENCE, 2001, 103 (01) : 117 - 123
12345